July 08, 2025
A recent review confirms the safety and efficacy of biosimilar insulins, addressing concerns and promoting their adoption for diabetes treatment.
July 07, 2025
July 05, 2025
July 04, 2025
July 03, 2025
January 12th 2024
By Cameron Santoro
Here are the top 5 biosimilar articles for the week of January 8, 2024.
January 11th 2024
By Skylar Jeremias
As Regeneron gears up for a legal battle with biosimilar competitors for its reference aflibercept, CareFirst files a lawsuit against Johnson & Johnson for restricting biosimilar ustekinumab competition; Celltrion and Accord BioPharma file with the FDA to approve their respective biosimilar candidates.
January 10th 2024
The European Medicines Agency (EMA) has granted marketing authorization to the first ustekinumab biosimilar, STADA Arzneimittel and Alvotech’s Uzpruvo.
IQVIA’s report on the impact biosimilar competition has had on Europe’s health care space identified ongoing challenges with biosimilar access and generating savings, calling for more policies focusing on fostering a sustainable market for years to come.
January 9th 2024
A recent study found that the COVID-19 pandemic had little impact on the knowledge and attitudes of German and Swiss pharmacists regarding biologics and biosimilars between 2020 and 2022.
January 8th 2024
By Sarfaraz K. Niazi, PhD
Sarafraz K. Niazi, PhD, previews the new year and his hopes for the end of clinical efficacy testing for biosimilar approvals using examples from history of other scientific concepts that took time to gain traction.
By The Center for Biosimilars Staff
Intro to Biosimilars is now in session! Test yourself on how well you know these biosimilar basics.
January 7th 2024
By Brooke McCormick
Prerakkumar Parikh, PharmD, director of specialty clinical solutions at Magellan Rx Management, reacts to recent FDA approvals for the first natalizumab and tocilizumab biosimilars.
January 6th 2024
Starting April 1, 2024, Hyrimoz and an unbranded version of Humira manufactured by Sandoz will be covered across all CVS formularies.
January 5th 2024
Here are the top 5 biosimilar articles for the week of January 1, 2024.